239000000232 Lipid Bilayer Substances 0.000 claims abstract description 26.230000004927 fusion Effects 0.000 claims abstract description 27.

239000004472 Lysine Substances 0.000 claims abstract description 38.239000000203 mixture Substances 0.000 claims abstract description 45.108090000623 proteins and genes Proteins 0.000 claims abstract description 46.

102000004169 proteins and genes Human genes 0.000 claims abstract description 46.

-1 (bispalmitoyloxy) -propyl-cysteinyl-seryl- (lysyl) Chemical group 0.000 claims abstract description 47.

241000700605 Viruses Species 0.000 claims abstract description 65.

150000002632 lipids Chemical class 0.000 claims abstract description 68.

239000000427 antigen Substances 0.000 claims abstract description 87.

108091007172 antigens Proteins 0.000 claims abstract description 88.

102000038129 antigens Human genes 0.000 claims abstract description 88.

230000000240 adjuvant Effects 0.000 title claims abstract description 85.

239000002671 adjuvant Substances 0.000 title claims abstract description 85.

230000003612 virological Effects 0.000 title claims abstract description 145.

239000012528 membrane Substances 0.000 title claims abstract description 163.

Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to NL0300450 priority Critical Priority to WOPCT/NL03/00450 priority Application filed by Bestewil Holding BV filed Critical Bestewil Holding BV Priority to PCT/NL2004/000437 priority patent/WO2004110486A1/en Application granted granted Critical Publication of ES2390454T3 publication Critical patent/ES2390454T3/en Status Active legal-status Critical Current Anticipated expiration legal-status Critical Links Original Assignee Bestewil Holding BV Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Inventor Antonius Johannes Hendrikus Stegmann Jan Christiaan Wilschut Johannes Henricus Gerardus Van Berkum Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number ES04748669T Other languages Spanish ( es) Functionally reconstituted viral membranes containing adjuvantĭownload PDF Info Publication number ES2390454T3 ES2390454T3 ES04748669T ES04748669T ES2390454T3 ES 2390454 T3 ES2390454 T3 ES 2390454T3 ES 04748669 T ES04748669 T ES 04748669T ES 04748669 T ES04748669 T ES 04748669T ES 2390454 T3 ES2390454 T3 ES 2390454T3 Authority ES Spain Prior art keywords seryl cysteinyl propyl lysyl lysine Prior art date Legal status (The legal status is an assumption and is not a legal conclusion.

Membrana de fantasma para que es